Skip to main content

Animations

MJFF Publications

4321 - 4330 of 8471 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • Summary Details
    RESTRICTED
    Title: Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s13311-020-00920-8
    Citation Count: 27
  • Summary Details
    RESTRICTED
    Title: Evaluation of motor response inhibition in Parkinson's Disease and Alzheimer's Disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.314
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Exploring the clinical burden of OFF periods in Parkinson disease
    Journal Name: The American Journal of Managed Care
    Publisher: Managed Care and Healthcare Communications, LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.37765/ajmc.2020.88517
    Best OA location URL:
    Citation Count: 15
  • Summary Details
    RESTRICTED
    Title: Exposure-response efficacy model of apomorphine sublingual film for the on-demand treatment of “OFF” episodes in patients with Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.311
    Best OA location URL:
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: Gene and Cell-Based Therapies for Parkinson's Disease: Where Are We?
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1007/s13311-020-00940-4
    Citation Count: 23
  • Summary Details
    OPEN
    Title: If LRRK2 Set the Fire, Can Nonsteroidal Anti‐inflammatory Drugs Wet the Flames?
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28240
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: Impact of Levodopa/Carbidopa Intestinal Gel Delivery on CarePartner Burden and Quality of Life: Survey by Parkinson & Movement disorder alliance
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.325
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Impact of OFF periods on aspects of employment for people with Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.323
    Best OA location URL:
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Management of Tardive Syndrome: Medications and Surgical Treatments
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s13311-020-00898-3
    Citation Count: 15
  • Summary Details
    RESTRICTED
    Title: Mechanisms behind Neurological Conditions Revealed, Adjusted
    Journal Name: Genetic Engineering & Biotechnology News
    Publisher: Mary Ann Liebert Inc
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1089/gen.40.10.15
    Best OA location URL:
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.